Loading…
Toxicological Property of Acetaminophen: The Dark Side of a Safe Antipyretic/Analgesic Drug?
Acetaminophen (paracetamol, N-acetyl-p-aminophenol; APAP) is the most popular analgesic/antipyretic agent in the world. APAP has been regarded as a safer drug compared with non-steroidal anti-inflammatory drugs (NSAIDs) particularly in terms of lower risks of renal dysfunction, gastrointestinal inju...
Saved in:
Published in: | Biological & pharmaceutical bulletin 2020/02/01, Vol.43(2), pp.195-206 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c702t-d0391f1998ef09afc92b4400cfead698a8e934b764c946bed04eedc900cdc2563 |
---|---|
cites | cdi_FETCH-LOGICAL-c702t-d0391f1998ef09afc92b4400cfead698a8e934b764c946bed04eedc900cdc2563 |
container_end_page | 206 |
container_issue | 2 |
container_start_page | 195 |
container_title | Biological & pharmaceutical bulletin |
container_volume | 43 |
creator | Ishitsuka, Yoichi Kondo, Yuki Kadowaki, Daisuke |
description | Acetaminophen (paracetamol, N-acetyl-p-aminophenol; APAP) is the most popular analgesic/antipyretic agent in the world. APAP has been regarded as a safer drug compared with non-steroidal anti-inflammatory drugs (NSAIDs) particularly in terms of lower risks of renal dysfunction, gastrointestinal injury, and asthma/bronchospasm induction, even in high-risk patients such as the elderly, children, and pregnant women. On the other hand, the recent increasing use of APAP has raised concerns about its toxicity. In this article, we review recent pharmacological and toxicological findings about APAP from basic, clinical, and epidemiological studies, including spontaneous drug adverse events reporting system, especially focusing on drug-induced asthma and pre-and post-natal closure of ductus arteriosus. Hepatotoxicity is the greatest fault of APAP and the most frequent cause of drug-induced acute liver failure in Western countries. However, its precise mechanism remains unclear and no effective cure beyond N-acetylcysteine has been developed. Recent animal and cellular studies have demonstrated that some cellular events, such as c-jun N-terminal kinase (JNK) pathway activation, endoplasmic reticulum (ER) stress, and mitochondrial oxidative stress may play important roles in the development of hepatitis. Herein, the molecular mechanisms of APAP hepatotoxicity are summarized. We also discuss the not-so-familiar “dark side” of APAP as an otherwise safe analgesic/antipyretic drug. |
doi_str_mv | 10.1248/bpb.b19-00722 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2350353773</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2349863878</sourcerecordid><originalsourceid>FETCH-LOGICAL-c702t-d0391f1998ef09afc92b4400cfead698a8e934b764c946bed04eedc900cdc2563</originalsourceid><addsrcrecordid>eNpdkc1r3DAQxUVpaLZpj70WQy-9OBl9WLZ6KcumTQuBBLK9FYQsj3e19VquZEP3v6-cTbeQiwb0frx5vCHkHYVLykR1VQ_1ZU1VDlAy9oIsKBdlXjBavCQLULTKJS2qc_I6xh0kBhh_Rc45g6SBXJCfa__HWd_5jbOmy-6DHzCMh8y32dLiaPau98MW-0_ZeovZtQm_sgfX4Kyb7MG0mC370Q2HgKOzV8vedBuMzmbXYdp8fkPOWtNFfPs0L8iPr1_Wq2_57d3N99XyNrcpz5g3wBVtqVIVtqBMaxWrhQCwLZpGqspUqLioSymsErLGBgRiY1UiGssKyS_Ix6PvEPzvCeOo9y5a7DrTo5-iZrwAXvCy5An98Azd-Smk2DMlVCV5VVaJyo-UDT7GgK0egtubcNAU9Fy7TrXrVLt-rD3x759cp3qPzYn-13MCbo5AUueifd-5Hv_vtrGsXbqCZsAgmQoOLA2qgapCpz_JhZQgy-S0Ojrt4mg2eFplQjpAh4_BBNdsfk4BT6rdmqCx538BleurJg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2349863878</pqid></control><display><type>article</type><title>Toxicological Property of Acetaminophen: The Dark Side of a Safe Antipyretic/Analgesic Drug?</title><source>Full-Text Journals in Chemistry (Open access)</source><creator>Ishitsuka, Yoichi ; Kondo, Yuki ; Kadowaki, Daisuke</creator><creatorcontrib>Ishitsuka, Yoichi ; Kondo, Yuki ; Kadowaki, Daisuke ; bDepartment of Clinical Pharmaceutics ; Faculty of Pharmaceutical Sciences ; Sojo University ; Kumamoto University ; Graduate School of Pharmaceutical Sciences ; aDepartment of Clinical Chemistry and Informatics</creatorcontrib><description>Acetaminophen (paracetamol, N-acetyl-p-aminophenol; APAP) is the most popular analgesic/antipyretic agent in the world. APAP has been regarded as a safer drug compared with non-steroidal anti-inflammatory drugs (NSAIDs) particularly in terms of lower risks of renal dysfunction, gastrointestinal injury, and asthma/bronchospasm induction, even in high-risk patients such as the elderly, children, and pregnant women. On the other hand, the recent increasing use of APAP has raised concerns about its toxicity. In this article, we review recent pharmacological and toxicological findings about APAP from basic, clinical, and epidemiological studies, including spontaneous drug adverse events reporting system, especially focusing on drug-induced asthma and pre-and post-natal closure of ductus arteriosus. Hepatotoxicity is the greatest fault of APAP and the most frequent cause of drug-induced acute liver failure in Western countries. However, its precise mechanism remains unclear and no effective cure beyond N-acetylcysteine has been developed. Recent animal and cellular studies have demonstrated that some cellular events, such as c-jun N-terminal kinase (JNK) pathway activation, endoplasmic reticulum (ER) stress, and mitochondrial oxidative stress may play important roles in the development of hepatitis. Herein, the molecular mechanisms of APAP hepatotoxicity are summarized. We also discuss the not-so-familiar “dark side” of APAP as an otherwise safe analgesic/antipyretic drug.</description><identifier>ISSN: 0918-6158</identifier><identifier>EISSN: 1347-5215</identifier><identifier>DOI: 10.1248/bpb.b19-00722</identifier><identifier>PMID: 32009106</identifier><language>eng</language><publisher>Japan: The Pharmaceutical Society of Japan</publisher><subject>Acetaminophen ; acetaminophen (APAP) ; Acetylcysteine ; Analgesics ; Asthma ; Bronchospasm ; c-Jun protein ; Drug overdose ; drug-induced asthma ; ductus arteriosus ; Endoplasmic reticulum ; endoplasmic reticulum stress ; Epidemiology ; Geriatrics ; Hepatitis ; Hepatotoxicity ; Inflammation ; JNK protein ; Liver diseases ; Mitochondria ; Molecular modelling ; Nonsteroidal anti-inflammatory drugs ; Oxidative stress ; Paracetamol ; Renal function ; Risk groups ; Transcription factors</subject><ispartof>Biological and Pharmaceutical Bulletin, 2020/02/01, Vol.43(2), pp.195-206</ispartof><rights>2020 The Pharmaceutical Society of Japan</rights><rights>Copyright Japan Science and Technology Agency 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c702t-d0391f1998ef09afc92b4400cfead698a8e934b764c946bed04eedc900cdc2563</citedby><cites>FETCH-LOGICAL-c702t-d0391f1998ef09afc92b4400cfead698a8e934b764c946bed04eedc900cdc2563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32009106$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ishitsuka, Yoichi</creatorcontrib><creatorcontrib>Kondo, Yuki</creatorcontrib><creatorcontrib>Kadowaki, Daisuke</creatorcontrib><creatorcontrib>bDepartment of Clinical Pharmaceutics</creatorcontrib><creatorcontrib>Faculty of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>Sojo University</creatorcontrib><creatorcontrib>Kumamoto University</creatorcontrib><creatorcontrib>Graduate School of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>aDepartment of Clinical Chemistry and Informatics</creatorcontrib><title>Toxicological Property of Acetaminophen: The Dark Side of a Safe Antipyretic/Analgesic Drug?</title><title>Biological & pharmaceutical bulletin</title><addtitle>Biol Pharm Bull</addtitle><description>Acetaminophen (paracetamol, N-acetyl-p-aminophenol; APAP) is the most popular analgesic/antipyretic agent in the world. APAP has been regarded as a safer drug compared with non-steroidal anti-inflammatory drugs (NSAIDs) particularly in terms of lower risks of renal dysfunction, gastrointestinal injury, and asthma/bronchospasm induction, even in high-risk patients such as the elderly, children, and pregnant women. On the other hand, the recent increasing use of APAP has raised concerns about its toxicity. In this article, we review recent pharmacological and toxicological findings about APAP from basic, clinical, and epidemiological studies, including spontaneous drug adverse events reporting system, especially focusing on drug-induced asthma and pre-and post-natal closure of ductus arteriosus. Hepatotoxicity is the greatest fault of APAP and the most frequent cause of drug-induced acute liver failure in Western countries. However, its precise mechanism remains unclear and no effective cure beyond N-acetylcysteine has been developed. Recent animal and cellular studies have demonstrated that some cellular events, such as c-jun N-terminal kinase (JNK) pathway activation, endoplasmic reticulum (ER) stress, and mitochondrial oxidative stress may play important roles in the development of hepatitis. Herein, the molecular mechanisms of APAP hepatotoxicity are summarized. We also discuss the not-so-familiar “dark side” of APAP as an otherwise safe analgesic/antipyretic drug.</description><subject>Acetaminophen</subject><subject>acetaminophen (APAP)</subject><subject>Acetylcysteine</subject><subject>Analgesics</subject><subject>Asthma</subject><subject>Bronchospasm</subject><subject>c-Jun protein</subject><subject>Drug overdose</subject><subject>drug-induced asthma</subject><subject>ductus arteriosus</subject><subject>Endoplasmic reticulum</subject><subject>endoplasmic reticulum stress</subject><subject>Epidemiology</subject><subject>Geriatrics</subject><subject>Hepatitis</subject><subject>Hepatotoxicity</subject><subject>Inflammation</subject><subject>JNK protein</subject><subject>Liver diseases</subject><subject>Mitochondria</subject><subject>Molecular modelling</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>Oxidative stress</subject><subject>Paracetamol</subject><subject>Renal function</subject><subject>Risk groups</subject><subject>Transcription factors</subject><issn>0918-6158</issn><issn>1347-5215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpdkc1r3DAQxUVpaLZpj70WQy-9OBl9WLZ6KcumTQuBBLK9FYQsj3e19VquZEP3v6-cTbeQiwb0frx5vCHkHYVLykR1VQ_1ZU1VDlAy9oIsKBdlXjBavCQLULTKJS2qc_I6xh0kBhh_Rc45g6SBXJCfa__HWd_5jbOmy-6DHzCMh8y32dLiaPau98MW-0_ZeovZtQm_sgfX4Kyb7MG0mC370Q2HgKOzV8vedBuMzmbXYdp8fkPOWtNFfPs0L8iPr1_Wq2_57d3N99XyNrcpz5g3wBVtqVIVtqBMaxWrhQCwLZpGqspUqLioSymsErLGBgRiY1UiGssKyS_Ix6PvEPzvCeOo9y5a7DrTo5-iZrwAXvCy5An98Azd-Smk2DMlVCV5VVaJyo-UDT7GgK0egtubcNAU9Fy7TrXrVLt-rD3x759cp3qPzYn-13MCbo5AUueifd-5Hv_vtrGsXbqCZsAgmQoOLA2qgapCpz_JhZQgy-S0Ojrt4mg2eFplQjpAh4_BBNdsfk4BT6rdmqCx538BleurJg</recordid><startdate>20200201</startdate><enddate>20200201</enddate><creator>Ishitsuka, Yoichi</creator><creator>Kondo, Yuki</creator><creator>Kadowaki, Daisuke</creator><general>The Pharmaceutical Society of Japan</general><general>Pharmaceutical Society of Japan</general><general>Japan Science and Technology Agency</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20200201</creationdate><title>Toxicological Property of Acetaminophen: The Dark Side of a Safe Antipyretic/Analgesic Drug?</title><author>Ishitsuka, Yoichi ; Kondo, Yuki ; Kadowaki, Daisuke</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c702t-d0391f1998ef09afc92b4400cfead698a8e934b764c946bed04eedc900cdc2563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acetaminophen</topic><topic>acetaminophen (APAP)</topic><topic>Acetylcysteine</topic><topic>Analgesics</topic><topic>Asthma</topic><topic>Bronchospasm</topic><topic>c-Jun protein</topic><topic>Drug overdose</topic><topic>drug-induced asthma</topic><topic>ductus arteriosus</topic><topic>Endoplasmic reticulum</topic><topic>endoplasmic reticulum stress</topic><topic>Epidemiology</topic><topic>Geriatrics</topic><topic>Hepatitis</topic><topic>Hepatotoxicity</topic><topic>Inflammation</topic><topic>JNK protein</topic><topic>Liver diseases</topic><topic>Mitochondria</topic><topic>Molecular modelling</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>Oxidative stress</topic><topic>Paracetamol</topic><topic>Renal function</topic><topic>Risk groups</topic><topic>Transcription factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ishitsuka, Yoichi</creatorcontrib><creatorcontrib>Kondo, Yuki</creatorcontrib><creatorcontrib>Kadowaki, Daisuke</creatorcontrib><creatorcontrib>bDepartment of Clinical Pharmaceutics</creatorcontrib><creatorcontrib>Faculty of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>Sojo University</creatorcontrib><creatorcontrib>Kumamoto University</creatorcontrib><creatorcontrib>Graduate School of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>aDepartment of Clinical Chemistry and Informatics</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biological & pharmaceutical bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ishitsuka, Yoichi</au><au>Kondo, Yuki</au><au>Kadowaki, Daisuke</au><aucorp>bDepartment of Clinical Pharmaceutics</aucorp><aucorp>Faculty of Pharmaceutical Sciences</aucorp><aucorp>Sojo University</aucorp><aucorp>Kumamoto University</aucorp><aucorp>Graduate School of Pharmaceutical Sciences</aucorp><aucorp>aDepartment of Clinical Chemistry and Informatics</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Toxicological Property of Acetaminophen: The Dark Side of a Safe Antipyretic/Analgesic Drug?</atitle><jtitle>Biological & pharmaceutical bulletin</jtitle><addtitle>Biol Pharm Bull</addtitle><date>2020-02-01</date><risdate>2020</risdate><volume>43</volume><issue>2</issue><spage>195</spage><epage>206</epage><pages>195-206</pages><issn>0918-6158</issn><eissn>1347-5215</eissn><abstract>Acetaminophen (paracetamol, N-acetyl-p-aminophenol; APAP) is the most popular analgesic/antipyretic agent in the world. APAP has been regarded as a safer drug compared with non-steroidal anti-inflammatory drugs (NSAIDs) particularly in terms of lower risks of renal dysfunction, gastrointestinal injury, and asthma/bronchospasm induction, even in high-risk patients such as the elderly, children, and pregnant women. On the other hand, the recent increasing use of APAP has raised concerns about its toxicity. In this article, we review recent pharmacological and toxicological findings about APAP from basic, clinical, and epidemiological studies, including spontaneous drug adverse events reporting system, especially focusing on drug-induced asthma and pre-and post-natal closure of ductus arteriosus. Hepatotoxicity is the greatest fault of APAP and the most frequent cause of drug-induced acute liver failure in Western countries. However, its precise mechanism remains unclear and no effective cure beyond N-acetylcysteine has been developed. Recent animal and cellular studies have demonstrated that some cellular events, such as c-jun N-terminal kinase (JNK) pathway activation, endoplasmic reticulum (ER) stress, and mitochondrial oxidative stress may play important roles in the development of hepatitis. Herein, the molecular mechanisms of APAP hepatotoxicity are summarized. We also discuss the not-so-familiar “dark side” of APAP as an otherwise safe analgesic/antipyretic drug.</abstract><cop>Japan</cop><pub>The Pharmaceutical Society of Japan</pub><pmid>32009106</pmid><doi>10.1248/bpb.b19-00722</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0918-6158 |
ispartof | Biological and Pharmaceutical Bulletin, 2020/02/01, Vol.43(2), pp.195-206 |
issn | 0918-6158 1347-5215 |
language | eng |
recordid | cdi_proquest_miscellaneous_2350353773 |
source | Full-Text Journals in Chemistry (Open access) |
subjects | Acetaminophen acetaminophen (APAP) Acetylcysteine Analgesics Asthma Bronchospasm c-Jun protein Drug overdose drug-induced asthma ductus arteriosus Endoplasmic reticulum endoplasmic reticulum stress Epidemiology Geriatrics Hepatitis Hepatotoxicity Inflammation JNK protein Liver diseases Mitochondria Molecular modelling Nonsteroidal anti-inflammatory drugs Oxidative stress Paracetamol Renal function Risk groups Transcription factors |
title | Toxicological Property of Acetaminophen: The Dark Side of a Safe Antipyretic/Analgesic Drug? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T12%3A21%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Toxicological%20Property%20of%20Acetaminophen:%20The%20Dark%20Side%20of%20a%20Safe%20Antipyretic/Analgesic%20Drug?&rft.jtitle=Biological%20&%20pharmaceutical%20bulletin&rft.au=Ishitsuka,%20Yoichi&rft.aucorp=bDepartment%20of%20Clinical%20Pharmaceutics&rft.date=2020-02-01&rft.volume=43&rft.issue=2&rft.spage=195&rft.epage=206&rft.pages=195-206&rft.issn=0918-6158&rft.eissn=1347-5215&rft_id=info:doi/10.1248/bpb.b19-00722&rft_dat=%3Cproquest_cross%3E2349863878%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c702t-d0391f1998ef09afc92b4400cfead698a8e934b764c946bed04eedc900cdc2563%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2349863878&rft_id=info:pmid/32009106&rfr_iscdi=true |